首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   30898篇
  免费   3056篇
  国内免费   2220篇
耳鼻咽喉   334篇
儿科学   370篇
妇产科学   365篇
基础医学   3671篇
口腔科学   554篇
临床医学   4141篇
内科学   4529篇
皮肤病学   388篇
神经病学   1591篇
特种医学   1136篇
外国民族医学   19篇
外科学   2823篇
综合类   5235篇
现状与发展   7篇
一般理论   6篇
预防医学   2268篇
眼科学   902篇
药学   3347篇
  19篇
中国医学   1864篇
肿瘤学   2605篇
  2024年   335篇
  2023年   490篇
  2022年   1250篇
  2021年   1595篇
  2020年   1277篇
  2019年   1100篇
  2018年   1132篇
  2017年   1127篇
  2016年   1031篇
  2015年   1411篇
  2014年   1841篇
  2013年   1673篇
  2012年   2404篇
  2011年   2539篇
  2010年   1586篇
  2009年   1264篇
  2008年   1665篇
  2007年   1629篇
  2006年   1515篇
  2005年   1495篇
  2004年   1042篇
  2003年   988篇
  2002年   851篇
  2001年   691篇
  2000年   604篇
  1999年   623篇
  1998年   408篇
  1997年   369篇
  1996年   274篇
  1995年   295篇
  1994年   250篇
  1993年   181篇
  1992年   205篇
  1991年   191篇
  1990年   137篇
  1989年   139篇
  1988年   132篇
  1987年   101篇
  1986年   80篇
  1985年   61篇
  1984年   28篇
  1983年   42篇
  1981年   18篇
  1980年   13篇
  1979年   15篇
  1978年   7篇
  1977年   8篇
  1976年   7篇
  1974年   7篇
  1973年   9篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
目的 比较甘露醇、蓖麻油、复方聚乙二醇电解质散在老年科肠道镜检肠道准备的效果、耐受性及不良反应发生率.方法 选取门诊及同期住院进行肠镜检查的93例老年病人(分为甘露醇组31例,蓖麻油组32例,复方聚乙二醇电解质散组30例),对肠道准备过程中清洁肠道的效果、病人的耐受性和胃肠道反应情况进行比较.结果 甘露醇组、蓖麻油组、复方聚乙二醇电解质散组发生肠胃肠道反应者分别为7例、12例和3例,复方聚乙二醇电解质散组与前两组比较,p<0.05;不能耐受者甘露醇组、蓖麻油组和复方聚乙二醇电解质散组分别为7例、9例和1例,复方聚乙二醇电解质散组与前两组比较,p<0.05;肠道清洁度Ⅰ Ⅱ级者甘露醇组、蓖麻油组和复方聚乙二醇电解质散组分别为12例、11例和28例,复方聚乙二醇电解质散组明显优于前2组,p<0.05.结论 复方聚乙二醇电解质散有明显的泻下作用,病人耐受性好,胃肠道反应少而轻,清洁肠道效果明显优于甘露醇和蓖麻油.  相似文献   
42.

Purpose

Chondrosarcoma (CHS) in the spine is relatively rare and minimal information has been published in the literature regarding this subject. The objective of our study was to discuss the factors that may affect outcomes of patients with spinal CHS.

Methods

Univariate and multivariate analyses were performed to identify prognostic factors for recurrence, distant metastasis, and survival of spinal CHS. T test, χ 2 test and rank sum test were used to analyze a single factor for recurrence and metastasis, while survival rate was estimated using the Kaplan–Meier method. Factors with p values of ≤0.1 were subjected to multivariate analyses by binary logistic regression analyses or Cox regression analyses. p Values of ≤0.05 were considered statistically significant.

Results

A total of 98 patients with spinal CHS were included in the study. The mean follow-up period was 49.7 months (range 6–178). Recurrence was detected in 42 patients after initial surgery in our center, while distant metastasis and death occurred in 24 and 32 cases, respectively. The statistical analyses suggested that pathology grade III was closely related with distant metastasis which was an independent prognostic factor for overall survival. Total en bloc spondylectomy could significantly decrease the risk of recurrence, distant metastasis, and death of patients with spinal CHS.

Conclusions

Total en bloc spondylectomy could significantly decrease the risk of recurrence and distant metastasis, and meanwhile improve overall survival of spinal CHS. Distant metastasis which was closely associated with pathology grade III was an adverse prognostic factor for overall survival of spinal CHS.  相似文献   
43.
44.
Serotonin plays an important role in mood regulation, but the involvement of serotonin pathway genes in the development of bipolar I disorder (BP-I), a mood disorder, is not clear. We selected 21 singlenucleotide polymorphisms (SNPs) within the HTR2A gene, 8 within the SLC6A4 gene and 23 within the TPH2 gene for genotyping using the GoldenGate genotyping assay. A total of 375 patients with BP-I and 475 normal controls were recruited. Two out of 21 SNPs (rs1475196 and rs9567747) in the HTR2A gene and 1/23 SNPs (rs17110566) in the TPH2 gene were significantly associated with BP-I, both genotype-wise and allele-wise. Furthermore, a specific haplotype in the HTR2A gene showed a significant association with BP-I. Our results indicate that the HTR2A and TPH2 genes in the serotonin pathway play important roles in susceptibility to BP-I.  相似文献   
45.
In this study, we have developed microsatellite markers for the giant mottled eel (Anguilla marmorata) from expressed sequence tag (EST) sequences using next-generation sequencing. Consequently, a total of 39 novel polymorphic microsatellite markers were identified in 32 individuals from Wangquan River wild population area. The range of observed heterozygosity, expected heterozygosity and polymorphism information content were 0.044–1.000, 0.285–0.946 and 0.3783–0.9016, respectively. In addition, eight loci were deviated from Hardy–Weinberg equilibrium and modified by Bonferroni correction, and the results showed no significant linkage disequilibrium between the locus pair. The amplification of cross-species was conducted in Anguilla bicolor pacifica and Anguilla japonica, which revealed the applicability of EST-SSR primers. These EST-SSR markers can provide sufficient polymorphism for population genetic studies, pedigree and genome mapping of these three kinds of closely related eels.  相似文献   
46.
47.
While many previous studies have reported an association between the p.R229Q variant of the NPHS2 gene and focal segmental glomerulosclerosis (FSGS) or steroid-resistant nephrotic syndrome (SRNS), a conclusive relationship has not been defined. In this study, we performed a meta-analysis of the published data to investigate the impact of the p.R229Q polymorphism on FSGS and SRNS patients. Despite significant heterogeneity within some of the comparisons, the results revealed significantly higher risks of SRNS in individuals homozygous for the variant allele (OR 7.411, 95 % confidence interval 1.876–29.436, p = 0.004) compared to homozygous non-variant individuals. However, the carrier rate of the p.R229Q variant was not significantly different between SRNS patients and steroid-sensitive nephrotic syndrome patients. No statistically significant differences in the p.R229Q carrier rate were observed between FSGS patients and controls or FSGS patients and patients with different pathology classifications. No notable differences in the p.R229Q carrier rate were found between patients and controls in any group with early-onset disease (onset age < 18). In conclusion, our meta-analysis suggests that for adult-onset disease (onset age > 18), the homozygous variant could be a potential predictor of hereditary nephrotic syndrome and that the p.R229Q allele cannot currently be considered a risk factor for predicting FSGS.  相似文献   
48.
49.
50.
Background: Acute kidney injury (AKI) during sepsis is associated with poor outcome. However, diagnosis of AKI with serum creatinine (SCr) level change is neither highly sensitive nor specific. Therefore, identification of novel biomarkers for early diagnosis of AKI is desirable. Aims: To evaluate the capacity of combining urinary netrin-1 and human kidney injury molecule type 1 (KIM-1) in the early diagnosis of septic AKI. Methods: We prospectively recruited 150 septic patients from Jun 2011 to Jun 2013 at Zhejiang Provincial People's Hospital, China. SCr, urinary netrin-1, and KIM-1 levels were recorded at 0, 1, 3, 6, 24, and 48?h of ICU admission and compared between AKI and non-AKI patients. In addition, we investigated the prognostic value of netrin-1 and KIM-1 between non-survivors and survivors in septic AKI patients. Results: SCr levels started to show elevation after 24?h of ICU admission. However, netrin-1 levels increased significantly as early as 1?h, peaked at 3–6?h and remained elevated up to 48?h of ICU admission in septic AKI patients. KIM-1 increased significantly by 6?h, peaked at 24?h and remained significantly elevated until 48?h of ICU admission. Furthermore, we observed significant higher urinary KIM-1 levels at 24?h and 48?h in non-survivors compared to survivors in AKI patients. Conclusions: Our results suggest that both netrin-1 and KIM-1 are clinically useful as early biomarkers in the diagnosis of septic AKI. In addition, persistent elevation of urinary KIM-1 level may be associated with poor prognosis.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号